NCT00873275 2025-06-22
Ursodiol, Combination Chemotherapy, and Bevacizumab in Treating Patients With Stage IV Colorectal Cancer
City of Hope Medical Center
Phase 1 Completed
Clinical Trials
12 trialsNCT01652196 2025-02-05
Aflibercept and FOLFOX6 Treatment for Previously Untreated Stage IV Colorectal Cancer
Ohio State University Comprehensive Cancer Center
Phase 2 Completed
NCT03993327 2024-06-28
An Imaging Agent (I-124 M5A) in Detecting CEA-Positive Liver Metastases in Patients With Colorectal Cancer
City of Hope Medical Center
Phase 1 Completed
NCT00207298 2019-01-10
18F-fluorodeoxyglucose (18F-FDG) Positron Emission Tomography in Oncology
British Columbia Cancer Agency
Completed
NCT00410618 2018-07-06
Neurological Effects of Chemotherapy and Radiation Therapy in Patients With Colon Cancer
University of Arizona
Completed
NCT00242086 2016-06-01
Comparison of Triphasic CT, PET and MR Tumour With Pathological Findings in Colorectal Cancer Liver Metastases
University Health Network, Toronto
Phase NA Completed
NCT01821105 2016-03-02
2 Phase Comparison of Pre-operative CT and PET Images for Metastatic Colorectal Cancer
Ohio State University Comprehensive Cancer Center
Phase 2 Completed
NCT00123760 2016-02-25
Study of 18F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Cancer or Suspected Cancer
AHS Cancer Control Alberta
Phase 2/3 Completed
NCT00004891 2015-12-22
PET and CT Scans in Patients With Locally Advanced Primary Rectal Cancer That Can Be Removed During Surgery
Memorial Sloan Kettering Cancer Center
Phase NA Completed
NCT00764621 2014-11-04
Health Economic Evaluation of Primovist-enhanced Liver MRI
Bayer
Phase 4 Completed
NCT00265356 2013-10-21
PETCAM
Ontario Clinical Oncology Group (OCOG)
Phase 3 Completed
NCT00499395 2012-04-03
Fludeoxyglucose F 18-PET Imaging for Early Detection of Residual Disease in Patients Undergoing Radiofrequency Ablation of Liver Metastases From Colorectal Cancer
UNC Lineberger Comprehensive Cancer Center
Phase NA Completed